SPECIAL REPORT / Pharmaceutical companies hesitate before investing in brain research, as it is seen as an overly complex area, but a European Commission initiative is a step in the right direction, according to the European Brain Council (EBC).
The direct cost of healthcare in Europe related to brain diseases has soared from €386 billion in 2004 to to €798 billion in 2010, according to data from 30 European countries, highlighting the need for research in that area.
image: http://www.freedigitalphotos.net
